Intellia Therapeutics (NTLA) Shares Issued (2015 - 2026)

Intellia Therapeutics (NTLA) has 12 years of Shares Issued data on file, last reported at $5.6 million in Q1 2026.

• On a quarterly basis, Shares Issued fell 4.56% year-over-year to $5.6 million in Q1 2026; TTM through Mar 2026 was $5.6 million, a 4.56% decrease from a year earlier, with the FY2025 full-year figure at $5.2 million, down 4.42% from the prior year.
• Shares Issued for Q1 2026 stood at $5.6 million, up from $5.2 million in the prior quarter.
• Over the last five years, Shares Issued for NTLA reached as high as $5.9 million in Q1 2023 and fell as low as $2.4 million in Q1 2022.
• Historically, Shares Issued has averaged $4.6 million across 5 years, with a median of $5.2 million in 2025.
• Across the five-year window, Shares Issued slumped 67.49% in 2022 and jumped 142.83% in 2023, its largest moves.
• Year by year, Shares Issued stood at $5.5 million in 2022, then dropped by 0.23% to $5.5 million in 2023, then decreased by 0.85% to $5.4 million in 2024, then retreated by 4.42% to $5.2 million in 2025, then climbed by 8.89% to $5.6 million in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $5.6 million in Q1 2026, $5.2 million in Q4 2025, and $4.1 million in Q3 2025.